课题基金 / 基金详情

The avian interferon system and its evasion by Avipoxviruses

The avian interferon system and its evasion by Avipoxviruses
禽干扰素系统及其对禽痘病毒的逃避
批准号:
BB/G018332/1
负责人:
Steve Goodbourn
金额:
$38.86万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Steve Goodbourn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The interferon system plays a major role in the body's inbuilt (innate) immunity to pathogens, particularly to viruses. The innate immune system is the descendant of ancient mechanisms found in more primitive organisms. It represents a broad set of non-specific defences, the job of which is to repel the pathogen, or at least hold it in check until the host's acquired immune system can mount a quick response to pathogens it has seen before, or a slower response to those it has not. The interferon system also helps initiate and coordinate the initial acquired immune response. The importance and effectiveness of the interferon system has only become apparent in the last 10 to 12 years, and is best demonstrated by the pathogens themselves. All have evolved mechanisms, often multiple, to counteract the interferon system, preventing it being initiated ('induced'), amplified and executed. Across the family tree of viruses, a wide and diverse range of virus counter-defences are deployed, involving the activity of interferon 'modulators'. Interferon was first discovered in chicken cells by Isaacs & Lindemann in 1957 but, since then, our knowledge of the avian system has lagged behind that of the mammalian system. For instance the first chicken IFN sequence was determined only in 1994, 14 years after the first mammalian sequence. This has equally hampered our ability to investigate and understand the mechanisms by which viruses evade the avian IFN responses. For scientists studying avian innate responses and avian viruses, a 'catch-22' situation has existed. Without the tools to characterise the avian system, it has been extremely difficult to identify virus modulators of the system and, without the modulators, scientists have been denied some of the most useful tools for probing the intact system of the host. A previous joint grant awarded to us under the Combating Viral Diseases of Livestock Initiative proved an important way of helping to break this vicious circle. It was not possible to fully characterise all the components of the avian interferon system in one three-year grant but the study did confirm that the avian system, as expected, was substantially the same as the mammalian system(s). However, it also revealed important and unpredictable differences, which could well have important implications for the way that pathogens interact with avian hosts. This has important implications in terms of vaccination, which is widely practised in the worldwide poultry industry. It also goes without saying that significant differences between avian and mammalian systems could have important consequences for the tropism of emerging zoonotic agents, such as Avian influenza (Bird Flu H5N1) and West Nile virus. At the same time the project provided basic tools to study the induction and modulation of the avian interferon response by representative avian viral pathogens and even to facilitate the identification and preliminary characterisation of novel interferon modulators from one complex avian pathogen, FWPV (a poxvirus - a family well known for deploying a wide range of interferon modulators in mammals). This proposal aims to build on that broad overview in two ways. Firstly it aims to focus on particular significant differences identified between the interferon systems of avian and mammalian hosts, and to clarify the consequences for both host and pathogens. To accomplish this it will be necessary to both understand how the avian interferon system functions in these key areas, and to identify how the novel viral modulators function. To identify whether the viral modulators target uniquely avian aspects, or whether they are broader in their specificity, will require clear and detailed characterisation of both host and viral mechanisms. Thus, although the two aims are fairly distinct, they are interwoven, interactive and interdependent.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Development of live attenuated vaccine candidates for Newcastle Disease Virus
  • 批准号:
    BB/R012792/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $50.51万
  • 财政年份:
    2018
  • 负责人:
    Steve Goodbourn
  • 依托单位:
Mechanism of action of an African swine fever virus virulence factor
  • 批准号:
    BB/E019781/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $33.46万
  • 财政年份:
    2007
  • 负责人:
    Steve Goodbourn
  • 依托单位:
国内基金
海外基金
系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
  • 批准号:
    21877063
  • 项目类别:
    面上项目
  • 资助金额:
    61.4万元
  • 批准年份:
    2018
  • 负责人:
    王鹏
  • 依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
干扰素信号分子及其调控网络在抗HBV感染过程中的作用机制研究
  • 批准号:
    81171558
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    宁琴
  • 依托单位:
糖药物蛋白Interferonβ N-glycan的均一、人源化改造
  • 批准号:
    81102361
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2011
  • 负责人:
    程剑松
  • 依托单位: